115 related articles for article (PubMed ID: 9724093)
1. Cyclocreatine inhibits stimulated motility in tumor cells possessing creatine kinase.
Mulvaney PT; Stracke ML; Nam SW; Woodhouse E; O'Keefe M; Clair T; Liotta LA; Khaddurah-Daouk R; Schiffmann E
Int J Cancer; 1998 Sep; 78(1):46-52. PubMed ID: 9724093
[TBL] [Abstract][Full Text] [Related]
2. Cyclocreatine (1-carboxymethyl-2-iminoimidazolidine) inhibits growth of a broad spectrum of cancer cells derived from solid tumors.
Lillie JW; O'Keefe M; Valinski H; Hamlin HA; Varban ML; Kaddurah-Daouk R
Cancer Res; 1993 Jul; 53(13):3172-8. PubMed ID: 8319226
[TBL] [Abstract][Full Text] [Related]
3. Antiproliferative effects of cyclocreatine on human prostatic carcinoma cells.
Hoosein NM; Martin KJ; Abdul M; Logothetis CJ; Kaddurah-Daouk R
Anticancer Res; 1995; 15(4):1339-42. PubMed ID: 7654018
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of creatine analogues as a new class of anticancer agents using freshly explanted human tumor cells.
Martin KJ; Chen SF; Clark GM; Degen D; Wajima M; Von Hoff DD; Kaddurah-Daouk R
J Natl Cancer Inst; 1994 Apr; 86(8):608-13. PubMed ID: 8145276
[TBL] [Abstract][Full Text] [Related]
5. Signal transduction for chemotaxis and haptotaxis by matrix molecules in tumor cells.
Aznavoorian S; Stracke ML; Krutzsch H; Schiffmann E; Liotta LA
J Cell Biol; 1990 Apr; 110(4):1427-38. PubMed ID: 2324200
[TBL] [Abstract][Full Text] [Related]
6. Hodgkin disease-derived cell lines expressing ubiquitous mitochondrial creatine kinase show growth inhibition by cyclocreatine treatment independent of apoptosis.
Kornacker M; Schlattner U; Wallimann T; Verneris MR; Negrin RS; Kornacker B; Staratschek-Jox A; Diehl V; Wolf J
Int J Cancer; 2001 Nov; 94(4):513-9. PubMed ID: 11745437
[TBL] [Abstract][Full Text] [Related]
7. Accumulation of analgo of phosphocreatine in muscle of chicks fed 1-carboxymethyl-2-iminoimidazolidine (cyclocreatine).
Griffiths GR; Walker JB
J Biol Chem; 1976 Apr; 251(7):2049-54. PubMed ID: 1270421
[TBL] [Abstract][Full Text] [Related]
8. Cyclocreatine inhibits the production of neutrophil chemotactic factors from isolated hearts.
Elgebaly SA; Allam ME; Rossomando EF; Cordis GA; Forouhar F; Farghaly A; Kreutzer DL
Am J Pathol; 1990 Nov; 137(5):1233-41. PubMed ID: 2240167
[TBL] [Abstract][Full Text] [Related]
9. Creatine and cyclocreatine treatment of human colon adenocarcinoma xenografts: 31P and 1H magnetic resonance spectroscopic studies.
Kristensen CA; Askenasy N; Jain RK; Koretsky AP
Br J Cancer; 1999 Jan; 79(2):278-85. PubMed ID: 9888469
[TBL] [Abstract][Full Text] [Related]
10. Liposomal Delivery of Cyclocreatine Impairs Cancer Cell Bioenergetics Mediating Apoptosis.
Ganguly S; Elbayoumi T
Methods Mol Biol; 2021; 2275():173-186. PubMed ID: 34118038
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotective effects of creatine and cyclocreatine in animal models of Huntington's disease.
Matthews RT; Yang L; Jenkins BG; Ferrante RJ; Rosen BR; Kaddurah-Daouk R; Beal MF
J Neurosci; 1998 Jan; 18(1):156-63. PubMed ID: 9412496
[TBL] [Abstract][Full Text] [Related]
12. Creatine and phosphocreatine analogs: anticancer activity and enzymatic analysis.
Bergnes G; Yuan W; Khandekar VS; O'Keefe MM; Martin KJ; Teicher BA; Kaddurah-Daouk R
Oncol Res; 1996; 8(3):121-30. PubMed ID: 8823808
[TBL] [Abstract][Full Text] [Related]
13. Cyclocreatine in cancer chemotherapy.
Teicher BA; Menon K; Northey D; Liu J; Kufe DW; Kaddurah-Daouk R
Cancer Chemother Pharmacol; 1995; 35(5):411-6. PubMed ID: 7850923
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of rate of tumor growth by creatine and cyclocreatine.
Miller EE; Evans AE; Cohn M
Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3304-8. PubMed ID: 8475072
[TBL] [Abstract][Full Text] [Related]
15. Direct determination of creatine kinase equilibrium constants with creatine or cyclocreatine substrate.
LoPresti P; Cohn M
Biochim Biophys Acta; 1989 Oct; 998(3):317-20. PubMed ID: 2804134
[TBL] [Abstract][Full Text] [Related]
16. Cyclocreatine Transport by SLC6A8, the Creatine Transporter, in HEK293 Cells, a Human Blood-Brain Barrier Model Cell, and CCDSs Patient-Derived Fibroblasts.
Uemura T; Ito S; Masuda T; Shimbo H; Goto T; Osaka H; Wada T; Couraud PO; Ohtsuki S
Pharm Res; 2020 Mar; 37(3):61. PubMed ID: 32124083
[TBL] [Abstract][Full Text] [Related]
17. Myocardial protection during ischemia by prior feeding with the creatine analog: cyclocreatine.
Jacobstein MD; Gerken TA; Bhat AM; Carlier PG
J Am Coll Cardiol; 1989 Jul; 14(1):246-51. PubMed ID: 2738267
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and accumulation of an extremely stable high-energy phosphate compound by muscle, heart, and brain of animals fed the creatine analog, 1-carboxyethyl-2-iminoimidazolidine (homocyclocreatine).
Roberts JJ; Walker JB
Arch Biochem Biophys; 1983 Feb; 220(2):563-71. PubMed ID: 6824340
[TBL] [Abstract][Full Text] [Related]
19. The synthetic phosphagen cyclocreatine phosphate inhibits the growth of a broad spectrum of solid tumors.
Schimmel L; Khandekar VS; Martin KJ; Riera T; Honan C; Shaw DG; Kaddurah-Daouk R
Anticancer Res; 1996; 16(1):375-80. PubMed ID: 8615639
[TBL] [Abstract][Full Text] [Related]
20. Kinetics of cyclocreatine and Na(+) cotransport in human breast cancer cells: mechanism of activity.
Maril N; Degani H; Rushkin E; Sherry AD; Cohn M
Am J Physiol; 1999 Oct; 277(4):C708-16. PubMed ID: 10516101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]